Related by context. All words. (Click for frequent words.) 67 biologics 66 fusion enhancers 61 TÎ ² 4 60 biosurgical 60 CTLA4 Ig 60 therapeutics 60 mTOR inhibitors 60 Onconase 59 anti angiogenic agents 59 antitumor 59 immune modulating 59 vascular disrupting agents 59 systemic antifungal 59 immuno inflammatory 59 biosimilar 58 immunomodulatory 58 microtubule inhibitor 58 pain palliation 58 Anidulafungin 58 Tß4 58 proteasome inhibitor 58 preclinical 58 Sudhir Agrawal D.Phil 58 biologic therapeutics 58 Hycamtin 58 MAb 58 small molecule 58 antitumoral 58 novel peptide 58 anti thrombotic 58 depsipeptide 58 echinocandin 58 anti secretory 58 rhThrombin 58 proteasome inhibitors 58 therapeutic monoclonal antibodies 58 Taxol ® 57 receptor inhibitor 57 cartilage regeneration 57 erlotinib Tarceva 57 Caelyx 57 etanercept Enbrel 57 VALSTAR 57 immune modulatory 57 dalbavancin 57 Panzem 57 antisense drug 57 NEUGENE antisense 57 oxazolidinone 57 Eribulin 57 DOS# 57 HQK 57 Vidaza azacitidine 57 kidney urologic 57 OncoVEX 57 CDP# 57 pamidronate 57 anti CD3 57 gefitinib Iressa 57 Factor VIIa 57 epothilone 57 Phage Pharmaceuticals 57 cytostatic 57 targeted radiotherapeutic 57 YONDELIS 57 therapeutic monoclonal antibody 57 anti CD# antibodies 57 TLR9 agonist 57 Chrysalin 57 HCV protease inhibitors 57 epothilones 57 therapeutic 57 bioabsorbable polymer 57 Solazed 57 QuadraSphere 57 beta lactam 57 NexACT ® 57 Onalta 57 Eraxis 57 clinical trial 56 tigecycline 56 humanised monoclonal antibody 56 Campath ® 56 HepaGam B 56 prodrugs 56 panitumumab Vectibix 56 taxol 56 antimetabolite 56 ixabepilone 56 OvaRex R 56 uric acid lowering 56 metaglidasen 56 oral antiviral 56 Proxinium TM 56 PDE4 inhibitor 56 Erbitux cetuximab 56 Carfilzomib 56 liposomal doxorubicin 56 MEK inhibitors 56 RECOTHROM R 56 chimeric monoclonal antibody 56 ADME properties 56 biologic therapy 56 Amrubicin 56 IV Busulfex 56 Sutent sunitinib 56 targeted antifolate 56 Urokinase 56 radiotherapeutic 56 rituximab Rituxan 56 PARP inhibition 56 postapproval 56 Humira adalimumab 56 biopharmaceuticals 56 inhibit EGFR 56 JAK inhibitor 56 liquid embolic 56 Gleevec resistant 56 Ethyol 56 histone deacetylase HDAC inhibitors 56 Bucindolol 56 vinca alkaloid 56 Combidex 56 Vfend 56 antibody 56 therapeutic proteins 56 anticancer agent 56 recombinant protein 56 anticancer therapy 56 Panzem R NCD 56 biomarker 56 dacetuzumab 56 biotherapeutic 56 Vilazodone 56 Thalomid ® 56 pregabalin Lyrica 56 Rebif ® 56 immuno modulatory 56 regenerative tissue 56 novel immunomodulatory 56 bioactive 56 IMiDs R 56 novel anticancer 56 oral antidiabetic 56 histone deacetylase HDAC 56 Gelclair 56 trabectedin 56 Vidaza 55 monoclonal 55 osteogenic 55 monoclonal antibodies 55 sorafenib Nexavar 55 IRX 2 55 Thrombin 55 Cerashield 55 personalized immunotherapy 55 Neuradiab 55 Maxy G# 55 MGd 55 Interferon beta 55 clofarabine 55 TNF alpha inhibitors 55 HSP# inhibitor 55 osteoinductive 55 nucleoside analogs 55 Genentech Herceptin 55 Abelcet 55 Dasatinib 55 immuno oncology 55 cytotoxics 55 Nexavar sorafenib 55 Metvix 55 Cellcept 55 nucleoside 55 vidofludimus 55 TKM ApoB 55 delafloxacin 55 Cancidas 55 Aviptadil 55 cellular immunotherapy 55 pharmacological 55 cintredekin besudotox 55 immune suppressive 55 ALN TTR# 55 Cardio Vascu Grow 55 BrachySil 55 Adnectin 55 siRNA therapeutics 55 humanized monoclonal antibodies 55 FK# 55 DXL# 55 Pemetrexed 55 molecularly targeted 55 Treanda 55 OvaRex ® MAb 55 dermaPACE TM 55 fibrin sealant 55 indibulin 55 IAP inhibitor 55 JAK3 inhibitor 55 Preclinical studies suggest 55 vitamin D analogs 55 atacicept 55 potent antiproliferative 55 Taxol paclitaxel 55 Genentech Rituxan 55 CYT# potent vascular disrupting 55 thalidomide Thalomid 55 TREANDA 55 OncoVEX GM CSF 55 EGFR tyrosine kinase inhibitors 55 Oncaspar 55 PrevOnco 55 Cx# [002] 55 Nanobodies 55 Degarelix 55 biomaterial 55 EGFR pathway 55 stem cell therapeutics 55 BiTE 55 therapies 55 clinical 55 Sporanox 55 immunosuppressant 55 bovine thrombin 55 bioabsorbable 55 Evithrom 55 UCB Cimzia 55 LEUKINE 55 factor TNF 55 multitargeted 55 radiation sensitizer 55 echinocandins 55 Campath alemtuzumab 55 cannabinor 55 Zolinza 55 Vorinostat 55 chemical entities NCEs 55 KRAS mutant 55 potency selectivity 55 molecular biomarkers 55 intranasal delivery 55 proprietary biomaterials 55 STEDESA 55 #ME# 55 antitumor effect 55 bevacizumab Avastin ® 55 immunotherapeutic agent 55 Zavesca R 55 kinase inhibition 55 kallikrein 55 HuMax CD# 55 clinical trials 55 IMiDs ® compound 55 parthenolide 55 MAXY G# 55 alpha interferon 55 botanically derived 55 myelofibrosis polycythemia vera 55 Temsirolimus 55 small molecule activators 55 viscosupplementation 55 YONDELIS R 55 biologicals 55 angiogenesis inhibitor 54 Advexin 54 p# inhibitors 54 topical dermatology 54 alefacept 54 pharmacoeconomic 54 HuMax CD4 54 PREOS 54 ALK inhibitors 54 injectable gel 54 anti TNF 54 ONCASPAR 54 hPTH #-# 54 TYZEKA 54 RhuDex ® 54 monoclonal antibody 54 genomic biomarkers 54 recombinant 54 TELINTRA 54 topical antifungal 54 E2F Decoy 54 anti CD3 antibody 54 AAG geldanamycin analog 54 TLR agonists 54 Sebivo 54 inhibit viral replication 54 selective inhibition 54 tubulin binding 54 mesylate 54 preclinical efficacy 54 dasatinib Sprycel 54 antimitotic 54 immunoregulatory 54 Cethrin R 54 ADVEXIN 54 cetuximab Erbitux R 54 Sensipar 54 synthetic retinoid 54 bone morphogenetic proteins BMPs 54 oncology 54 Myocet 54 peptidic 54 ridaforolimus 54 antiangiogenic therapy 54 SERMs 54 Vidofludimus 54 potent anticancer 54 Archexin 54 PSN# [002] 54 inhibit angiogenesis 54 acetonide FA 54 ESBA# 54 mecamylamine 54 generation antisense 54 pharmacodynamic properties 54 CB2 receptor 54 prostone 54 Squalamine 54 integrase inhibitor 54 alkylating agent 54 ABRAXANE ® 54 Hyphanox 54 sulodexide 54 beta lactam antibiotic 54 vemurafenib 54 alkylating 54 Hedgehog inhibitor 54 Trofex 54 therapeutic peptide 54 dermaceutical 54 metabolomic profiles 54 erythropoietic 54 miglustat 54 cyclosporin 54 antitumour 54 Gleevec imatinib mesylate 54 plasma kallikrein inhibitor 54 antithrombotic 54 novel histone deacetylase 54 Tolevamer 54 salmon calcitonin 54 Aganocide 54 NEUMUNE 54 synthetic peptides 54 Orencia abatacept 54 Excellarate 54 biotherapies 54 Gefitinib 54 VEGF inhibitors 54 Epothilones 54 PORxin TM 54 PEGPH# 54 Kepivance 54 paclitaxel Taxol 54 rxRNA 54 Gemzar gemcitabine 54 ganetespib 54 HepDirect prodrug 54 Xcytrin R 54 Tβ4 54 bortezomib Velcade 54 haemostatic 54 Fc receptor 54 Azedra 54 biogeneric 54 candidate deforolimus 54 carbohydrate polymers 54 Valdoxan 54 cediranib 54 oral anticancer 54 rFVIII 54 Amplimexon 54 psoriasis rheumatoid arthritis 54 haematologic 54 ZEVALIN ® 54 pharmacogenetic testing 54 monoclonal antibody therapies 54 clevidipine 54 Vitagel 54 Rituxan rituximab 54 verteporfin 54 A3 adenosine receptor 54 allogeneic HSCT 54 anti angiogenic drugs 54 tolevamer 54 Noxafil 54 therapeutic antibody 54 lyophilized 54 anticancer therapies 54 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 54 PROCHYMAL 54 PDE# inhibitors 54 biomarker identification 54 Yondelis ® 54 betamethasone dipropionate 54 JAK3 54 vernakalant hydrochloride 54 epigenetic therapies 54 extracellular matrix ECM 54 Phylomer 54 immunotherapy 54 Pertuzumab 54 vivo 54 TNF alpha inhibitor 54 Urocidin 54 diagnostic assays 54 novel anti infective 54 pharmacodynamic markers 54 liposomal formulation 54 gemcitabine Gemzar 54 KineMed 54 belinostat 54 investigational humanized monoclonal antibody 54 preclinical toxicology 54 cytotoxic agents 54 daptomycin 54 Ustekinumab 54 Ceflatonin 54 topical formulations 54 pomalidomide 54 Velcade bortezomib 54 bone grafting procedures 54 Leukine ® 54 Mipomersen 54 Pyridorin 54 briakinumab 54 CoFactor 54 Aplidin 54 Wellstat 54 Pimavanserin 54 DAVANAT 54 Excellagen 54 antifibrotic 54 BioSilicon TM 54 thymosin beta 4 54 GEM #S 54 immune modulator 54 somatostatin analogues 54 p# inhibitor 54 Azedra TM 54 Arranon 54 Mepact 54 Vidaza R 54 targeting CD# 54 osteoconductive 54 alemtuzumab MS 54 treating neuropathic pain 54 AEG# 54 Eli Lilly Cymbalta 54 immunosuppressive 53 TLR9 agonists 53 Pazopanib 53 HspE7 53 Axitinib 53 GelSite R polymer 53 infectious diseases autoimmune diseases 53 MyVax R 53 mertansine 53 isoform selective 53 Fc fusion protein 53 levetiracetam Keppra 53 Targretin 53 bioscavenger 53 heparins 53 Sanofi Aventis Taxotere 53 protein tyrosine phosphatases 53 VEGF Trap 53 pharmacokinetic equivalence 53 EGFR antibodies 53 pharmacologic 53 cefepime 53 Xanafide 53 decitabine 53 INTEGRILIN 53 Cetuximab Erbitux 53 carbohydrate polymer 53 anticlotting 53 antiangiogenic 53 investigational compounds 53 anti infective 53 Fosrenol 53 GED aPC 53 cancer immunotherapies 53 antihormonal 53 CINTREDEKIN BESUDOTOX 53 Psoraxine R 53 oral prodrug 53 Civacir 53 gastrointestinal stromal tumors GIST 53 antibody MAb 53 protein homeostasis 53 Trabectedin 53 recombinant human 53 histone deacetylase HDAC inhibitor 53 ocular inflammatory 53 Celator 53 stent coating 53 IAP inhibitors 53 Cabazitaxel 53 Alequel ™ 53 Elvitegravir 53 tafamidis 53 Spinal implants 53 oral antifungal 53 pancreatic enzyme replacement 53 Ixempra 53 Dalbavancin 53 anti resorptive 53 Ontak 53 XmAb# 53 JAK2 inhibitor 53 antineoplastic agents 53 Cethrin 53 Abbott Humira 53 Alfacell proprietary ribonuclease 53 Tamibarotene 53 teriparatide 53 Hectorol 53 tumorigenicity 53 preclinically 53 Davanat 53 Allovectin 7 53 ASONEP 53 refractory ovarian cancer 53 topotecan 53 PEGylated 53 JAK inhibitors 53 GGF2 53 Fluconazole 53 hematologic oncology 53 Adentri 53 infliximab Remicade 53 ophthalmology dermatology cardiovascular disease 53 Targretin capsules 53 TriMix gel TM 53 Zemplar 53 Integrilin 53 NAGS deficiency 53 ADP receptor antagonist 53 antifungal agent 53 Combivir Kivexa 53 GPR# agonists 53 Seprafilm 53 anti leukemic 53 histone deacetylase inhibitor 53 polyketides 53 Actimmune ® 53 sodium thiosulfate STS 53 RNAi therapeutic targeting 53 Xinlay 53 Cyclosporin 53 eniluracil 53 Inhaled nitric oxide 53 transfection reagents 53 immunomodulation 53 intercellular signaling 53 resolvins 53 Dual Opioid 53 Hsp# inhibition 53 Nanobody 53 Linjeta ™ 53 favorable pharmacokinetic 53 Captisol enabled 53 ADAMTS# 53 invasive candidiasis 53 mAbs 53 antiangiogenic agent 53 reslizumab 53 HSP# inhibitors 53 tubulin inhibitor 53 PDE4 inhibitors 53 Anticalins 53 Evicel 53 biphosphonates 53 cytotoxicity assays 53 oncologic 53 racemate 53 IMC A# 53 disease modifying 53 docetaxel 53 microtubule targeting 53 Neulasta R 53 investigational drug 53 Dacogen injection 53 ENMD # 53 nucleotide analogues 53 immunotoxins 53 Cardiolite 53 Taxol 53 topical diclofenac 53 diagnostic biomarker 53 VESTAsync 53 brostallicin 53 Virulizin ® 53 Orally administered 53 Synavive 53 HCV antiviral 53 calcitonin 53 dermatological diseases 53 Zemiva TM 53 pharmacokinetic interactions 53 NP2 Enkephalin 53 Miacalcin 53 deacetylase inhibitors 53 Artelon ® 53 pegylated liposomal doxorubicin 53 biologically active 53 TRV# [001] 53 Altrazeal R 53 aesthetic dermatology 53 Generx TM 53 Soliris eculizumab 53 thymalfasin 53 LymphoStat B 53 treat enlarged prostate 53 tipifarnib 53 Abbokinase 53 coated stent 53 CDK inhibitors 53 imatinib Gleevec ® 53 PDGF receptor 53 MediVas 53 TELCYTA 53 CCR5 inhibitor 53 cutaneous lupus 53 tanespimycin 53 zoledronic acid Zometa 53 T DM1 53 SGLT 2 53 immunosuppressive therapies 53 pitavastatin 53 ZFP TF 53 Liprotamase 53 AVI NEUGENE 53 fluoroquinolone antibiotic 53 2DG 53 ProMune 53 Cremophor 53 Factor Xa inhibitor 53 EHT AGN 53 Myolimus 53 GRNVAC1 53 NexACT 53 surgical sealant 53 mAb 53 A1PI 53 Neovastat 53 TheraSphere 53 mimetics 53 Gliadel Wafer 53 drug zotarolimus 53 imatinib Gleevec 53 monoclonal antibody therapeutics 53 Symadex 53 rBChE 53 AutoloGel tm 53 Gelnique 53 cytoprotective 53 calcineurin inhibitors 53 topical ophthalmic 53 PI3K delta 53 immune modulation 53 RELISTOR ® 53 dorzolamide 53 MTP inhibitor 53 NB S# strontium malonate 53 Collategene 53 relapsed multiple myeloma 53 imiquimod cream 53 liposome formulation 53 secretory pathway 53 antiarrhythmic 53 immunomodulators 53 rNAPc2 53 systemic RNAi 53 OraTest R 53 TNF inhibitor 53 CellCept mycophenolate mofetil 53 MyoCell TM 53 itraconazole Sporanox 53 XYNTHA 53 bardoxolone methyl 53 chemotherapy induced neutropenia 53 Didronel 53 rheumatoid arthritis psoriasis Crohn 53 antineoplastic 53 glatiramer 53 Nebido 53 synthetic siRNA 53 EGF receptor 53 Hemospan 53 thrombogenic 53 orthobiologic 53 NovaBay Aganocide compounds 53 biosurgery 53 immunomodulatory properties 53 investigational therapies 53 synthetic anti infective 53 luliconazole 53 antiproliferative effects 53 Affibody ® molecules 53 clodronate 53 Marqibo TM 53 novel peptides 53 Tarceva TM 53 quinolone 53 angiogenesis inhibition 53 HuCNS SC ® 53 radiolabeled TM# 53 faropenem 53 Mycamine 53 Fludara ® 53 immunomodulatory therapy 53 Zarnestra 53 Belerofon 53 pegylated 53 systemic fungal infections 53 pharmacological chaperone 53 DACH platinum 53 eflornithine 53 novel oral anticoagulant 53 γ secretase 53 BCR ABL inhibitors 53 allogeneic cell 53 Avastin bevacizumab 53 PEGylated interferon 53 preclinical studies 53 interleukin IL -# 53 Levulan Kerastick 53 Protectans 53 biosimilars 53 therapeutic radiopharmaceuticals 53 Zenapax 53 BCG refractory 53 Helicobacter pylori eradication 53 epigenetic therapeutics 53 tissue regeneration 53 posaconazole 53 relapsed ovarian cancer 53 reteplase 53 chemotherapeutic regimen 53 VIBEX MTX 53 Enbrel Humira 53 sipuleucel T 53 ATL# [001] 53 mesenchymal cell 53 CD# antibody [001] 53 Mycograb 53 immunoregulation 53 oral immunomodulatory 53 Anticalins R 53 thetreatment 53 keratinocyte 53 biocompatibility 53 optical biosensors 53 biosimilar versions 53 Icatibant 53 protein kinase inhibitors 53 regenerative healing 53 breast cancer subtypes 53 IMiDs ® 53 Olmesartan 53 Fabry Disease 53 amphotericin B 53 MGCD# [001] 53 SIR Spheres 53 metabonomics 53 phosphate binder 53 predictive biomarkers 53 uricase 53 biotherapeutics 53 BRAF inhibitor 53 vitro assay 53 fluoropyrimidine 53 Azathioprine 53 molecular determinants 52 Cerashield ™ 52 Teriparatide 52 Evoltra ® 52 Aganocide TM 52 oral antiplatelet 52 itraconazole 52 antidiabetic 52 proliferative disorders 52 Prolastin A1PI 52 Homspera 52 drug eluting stent DES 52 erlotinib Tarceva ® 52 EVICEL 52 diagnostic biomarkers 52 M# rationally 52 Neulasta ® 52 Rituxan 52 RNAi therapeutic targeting PCSK9 52 Pfizer Sutent 52 BeneFIX 52 SGLT2 inhibitors 52 potent cytotoxic 52 BUPIVACAINE SURGICAL IMPLANT 52 molecular abnormalities 52 Monoclonal antibody 52 nonviral 52 recombinant interferon 52 Multiferon ® 52 Proleukin 52 pharmacologic approaches 52 fibrotic disorders 52 drug eluting stent 52 sorafenib tablets 52 proteoglycan 52 Actemra 52 potentiator 52 romiplostim 52 CA4P 52 methylnaltrexone bromide 52 anticancer 52 epoprostenol 52 imatinib resistant 52 macrolide antibiotics 52 chemotherapeutics 52 kinase inhibitors 52 antiplatelet therapies 52 AQ4N 52 Enhanze Technology 52 Erimos 52 Immunotherapeutic 52 oral dnaJP1 52 VEGF inhibitor 52 Chemophase 52 delipidation 52 methylnaltrexone 52 Novartis Reclast 52 regenerative therapies 52 posterolateral spine 52 GelSite polymer 52 zotarolimus 52 Tarmogen 52 Celgene Revlimid 52 Etoposide 52 AZX# 52 Atrasentan 52 lapatinib Tykerb 52 potent inducer 52 RNA antagonists 52 FUSILEV enhances 52 HuMax 52 Haemacure fibrin sealant 52 topical NSAID 52 Crofelemer 52 cilengitide 52 melanocortin receptors 52 ViaDerm 52 Solesta 52 Tasimelteon 52 Multiferon R 52 Vivaglobin 52 S/GSK# 52 KRN# 52 cytotoxic 52 Raptiva R 52 Orencia 52 investigational monoclonal antibody 52 endothelin antagonist 52 autologous cell 52 ADVEXIN therapy 52 Onalta ™ 52 Multikine 52 Pancreate 52 radiolabeled 52 Fodosine 52 bone morphogenetic proteins 52 adalimumab Humira 52 ceftobiprole 52 lipoglycopeptide 52 ABELCET 52 MYCAMINE 52 CB2 selective 52 INOmax 52 trastuzumab Herceptin ® 52 Paraplatin 52 terlipressin 52 effector function 52 neurotrophic 52 EP #R 52 antimuscarinic 52 Nanobody ® 52 Altrazeal ® 52 CBLC# 52 recombinant antibodies 52 anidulafungin 52 biologic therapies 52 tranilast 52 therapeutically relevant 52 neuroactive 52 adenosine A2A 52 MYDICAR ® 52 thrombopoietin TPO 52 insulin analogues 52 liposomal delivery 52 pegylated interferons 52 DURIN TM 52 polyclonal antibody 52 MGN# 52 Vascular Wrap TM 52 oncolytic 52 NanoCrystal Technology 52 nilotinib Tasigna ® 52 discodermolide 52 Rescula 52 humanized antibody 52 Onalta TM 52 Forteo 52 treat facial wrinkles 52 topical formulation 52 prodrug 52 renal anemia 52 interventional therapies 52 isoproterenol 52 synthetic siRNAs 52 immune mediated 52 quinoline 52 Platinol 52 XP #L 52 Fleximer R 52 TLR8 52 Apo2L 52 Fortical R 52 Th2 cytokines 52 temozolomide 52 PXD# 52 chemosensitivity 52 NanoTab 52 acne rosacea 52 TGR5 52 anticancer treatments 52 docetaxel Taxotere ® 52 Gammagard Liquid 52 hematopoietic cell 52 hyaluronan 52 ZOLINZA 52 humanized monoclonal antibody 52 Tarvacin TM 52 CB1 antagonists 52 Thalomid thalidomide 52 porcine derived 52 peptide antigens 52 Oracea TM 52 Dapagliflozin 52 Ampligen R 52 autologous cellular immunotherapy 52 subcutaneous formulation 52 candidate TNFerade biologic 52 tazarotene 52 Xencor XmAb 52 intranasal formulation 52 taxanes 52 Acute Radiation Syndrome ARS 52 Abatacept 52 diagnostic molecular imaging 52 elinogrel 52 biomarkers 52 torezolid phosphate 52 bioabsorbable stent 52 aurora kinase 52 NeoDisc 52 mitogen activated ERK kinase 52 peripheral vascular stent 52 Oxaliplatin 52 engineered RAP peptides 52 LibiGel ® 52 BiTE antibody 52 Anticalins ® 52 taxane 52 biosynthetic 52 molecular entities NMEs 52 Captisol 52 BN# [002] 52 vosaroxin 52 imatinib mesylate Gleevec 52 Taxotere docetaxel 52 Alimta pemetrexed 52 Teflaro 52 immunological 52 Filgrastim 52 edifoligide E2F Decoy 52 TEMODAL 52 L DOS# 52 immune globulin intravenous 52 AP# [003] 52 teduglutide 52 Lipofen 52 vapreotide acetate 52 vinorelbine tartrate 52 Betaseron ® 52 CEQ#